Literature DB >> 19433653

The expanding role of genetics in the lewy body diseases: the glucocerebrosidase gene.

James B Leverenz, Oscar L Lopez, Steven T Dekosky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19433653      PMCID： PMC2763140          DOI： 10.1001/archneurol.2009.61

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  18 in total

1.  The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.

Authors:  Ozlem Goker-Alpan; Grisel Lopez; Joseph Vithayathil; Joie Davis; Mark Hallett; Ellen Sidransky
Journal:  Arch Neurol       Date:  2008-10

2.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

3.  Analysis of the glucocerebrosidase gene in Parkinson's disease.

Authors:  Christine Sato; Angharad Morgan; Anthony E Lang; Shabnam Salehi-Rad; Toshitaka Kawarai; Yan Meng; Peter N Ray; Lindsay A Farrer; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

4.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Authors:  L N Clark; B M Ross; Y Wang; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

5.  Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.

Authors:  Ignacio F Mata; Ali Samii; Seth H Schneer; John W Roberts; Alida Griffith; Berta C Leis; Gerard D Schellenberg; Ellen Sidransky; Thomas D Bird; James B Leverenz; Debby Tsuang; Cyrus P Zabetian
Journal:  Arch Neurol       Date:  2008-03

Review 6.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

Review 7.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

8.  Association of glucocerebrosidase mutations with dementia with lewy bodies.

Authors:  Lorraine N Clark; Lykourgos A Kartsaklis; Rebecca Wolf Gilbert; Beatriz Dorado; Barbara M Ross; Sergey Kisselev; Miguel Verbitsky; Helen Mejia-Santana; Lucien J Cote; Howard Andrews; Jean-Paul Vonsattel; Stanley Fahn; Richard Mayeux; Lawrence S Honig; Karen Marder
Journal:  Arch Neurol       Date:  2009-05

9.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Authors:  N Tayebi; J Walker; B Stubblefield; E Orvisky; M E LaMarca; K Wong; H Rosenbaum; R Schiffmann; B Bembi; E Sidransky
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

10.  Gaucher disease and the synucleinopathies.

Authors:  Kathleen S Hruska; Ozlem Goker-Alpan; Ellen Sidransky
Journal:  J Biomed Biotechnol       Date:  2006
View more
  2 in total

1.  Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

Authors:  Karen E Murphy; Amanda M Gysbers; Sarah K Abbott; Nahid Tayebi; Woojin S Kim; Ellen Sidransky; Antony Cooper; Brett Garner; Glenda M Halliday
Journal:  Brain       Date:  2014-01-28       Impact factor: 13.501

Review 2.  Gaucher disease and the synucleinopathies: refining the relationship.

Authors:  Tessa N Campbell; Francis Y M Choy
Journal:  Orphanet J Rare Dis       Date:  2012-01-31       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.